HZNP GAPS UP

" In related news, EVP Jeffrey W. Sherman sold 28,352 shares of Horizon Therapeutics Public stock in a transaction on Monday, December 12th. The shares were sold at an average price of $111.45, for a total transaction of $3,159,830.40. Following the sale, the executive vice president now directly owns 54,501 shares in the company, valued at approximately $6,074,136.45. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In other Horizon Therapeutics Public news, EVP Jeffrey W. Sherman sold 28,352 shares of the company’s stock in a transaction that occurred on Monday, December 12th. The stock was sold at an average price of $111.45, for a total transaction of $3,159,830.40. Following the completion of the sale, the executive vice president now directly owns 54,501 shares of the company’s stock, valued at approximately $6,074,136.45. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Jeffrey W. Sherman sold 5,187 shares of the business’s stock in a transaction on Friday, January 6th. The shares were sold at an average price of $113.29, for a total transaction of $587,635.23. Following the completion of the transaction, the executive vice president now directly owns 49,314 shares in the company, valued at $5,586,783.06. The disclosure for this sale can be found here. 2.50% of the stock is owned by corporate insiders. "